Medtronic recalls MiniMed 630G and 670G insulin pumps due to a cybersecurity vulnerability that could allow unauthorized insulin delivery, risking hypoglycemia or hyperglycemia. Affected models include MiniMed 630G/ MMT-1715, MMT-1755, MMT-1754 and MiniMed 670G/ MMT-1780, MMT-1781, MMT-1782, MMT-1760, MMT-1761, MMT-1762, MMT-1740, MMT-1741, MMT-1742.
Medtronic identified a cybersecurity vulnerability in the MiniMed 600 series Insulin Pump Systems associated with the communication protocol that could allow unauthorized access to the pump system. This unauthorized access could be used to deliver too much or too little insulin through delivery of an unintended insulin bolus or because insulin delivery is slowed or stopped, which could lead to hypoglycemia or hyperglycemia. The Remote Bolus feature on insulin pumps should be turned off to prevent the unauthorized access.
Medtronic is recalling several models of insulin pumps (MiniMed 630G and 670G) because of a cybersecurity vulnerability that could let hackers control the pump and deliver incorrect insulin doses. This could cause dangerous blood sugar levels, including life-threatening hypoglycemia or hyperglycemia.
The pumps have a cybersecurity vulnerability that could allow unauthorized access to the system. This could lead to the pump delivering too much or too little insulin, or stopping insulin delivery entirely, which might cause dangerously low or high blood sugar levels.
People with diabetes who use the recalled insulin pumps are affected. Those who rely on the Remote Bolus feature for insulin delivery are at higher risk of incorrect dosing.
Check your pump's model number on the device or its packaging. The affected models include MiniMed 630G (MMT-1715, MMT-1755, MMT-1754) and MiniMed 670G (MMT-1780, MMT-1781, MMT-1782, MMT-1760, MMT-1761, MMT-1762, MMT-1740, MMT-1741, MMT-1742).
Disable the Remote Bolus feature on your insulin pump to prevent unauthorized insulin delivery.
Medtronic identified a cybersecurity vulnerability in the MiniMed 600 series insulin pumps that could allow unauthorized access to the pump system, potentially leading to incorrect insulin delivery.
The affected models include MiniMed 630G (MMT-1715, MMT-1755, MMT-1754) and MiniMed 670G (MMT-1780, MMT-1781, MMT-1782, MMT-1760, MMT-1761, MMT-1762, MMT-1740, MMT-1741, MMT-1742).
Check your pump's model number on the device or its packaging. The affected models include MiniMed 630G and 670G with the specific model numbers listed in the recall notice.
We’ve drafted a message you can send Medtronic to request your refund or repair — edit it as you like.
Subject: Recall Z-0193-2023 — Medtronic Medtronic Hello, I own a Medtronic that is covered by recall Z-0193-2023 from Medtronic. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
